Your browser doesn't support javascript.
loading
Molecular Targeted Therapy Approach to Musculoskeletal Tumors.
Ibe, Izuchukwu; Haynes, Monique; Koo, Andrew; Lindskog, Dieter; Friedlaender, Gary E; Lee, Francis Y.
Afiliação
  • Ibe I; Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, Center for Musculoskeletal Care, Yale New Haven Hospital, New Haven, CT.
  • Haynes M; Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, Center for Musculoskeletal Care, Yale New Haven Hospital, New Haven, CT.
  • Koo A; Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, Center for Musculoskeletal Care, Yale New Haven Hospital, New Haven, CT.
  • Lindskog D; Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, Center for Musculoskeletal Care, Yale New Haven Hospital, New Haven, CT.
  • Friedlaender GE; Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, Center for Musculoskeletal Care, Yale New Haven Hospital, New Haven, CT.
  • Lee FY; Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, Center for Musculoskeletal Care, Yale New Haven Hospital, New Haven, CT.
Tech Orthop ; 33(3): 135-139, 2018 Sep.
Article em En | MEDLINE | ID: mdl-36186916
ABSTRACT
The future of cancer treatment is promising. Although marred by years of plateau in outcomes, new avenues have been identified that are poised to change how we treat cancer. Molecular targeted therapy or targeted therapy is one of these methods. Molecular targeted therapy involves identifying specific pathways or markers that allow cancer cells to flourish. Once identified, specific molecules can be used to block proliferative pathways, thereby negatively impacting tumor growth. Targeting specific pathways that prolong the survival of the cancer cell can lead to a decreased cancer burden, and improved patient outcomes. This article reviews the tenets of molecular targeted therapy, common pathways, target acquisition for drug development, and the pathways that have been elucidated in musculoskeletal tumors.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Tech Orthop Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Tech Orthop Ano de publicação: 2018 Tipo de documento: Article